Product information and disease descriptionPlace of product in therapyApproaches to treatmentCurrent treatment options and standard of care
Trigger avoidance and patient education
1 evidence topic · 1 source
Bezuclastinib
Nonadvanced systemic mastocytosis
- Manufacturer
- Cogent Biosciences
- Regulatory submission
- NDA submitted December 2025
- Last updated